An exploratory study for pharmacokinetics, efficacy, and safety of pyridoxamine in peritoneal dialysis patients - An exploratory study for pharmacokinetics, efficacy, and safety of pyridoxamine in PD patients

The University of Tokyo Hospital0 个研究点目标入组 6 人开始时间: 2016年10月15日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方: The University of Tokyo Hospital
入组人数: 6

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

Since it was difficult to measure pyridoxamine concentration, we reported the results of analysis of data other than pyridoxamine at a meeting for investigators of pyridoxamine in dialysis patients.

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 80years-old（—）
性别: All

入选标准

未提供

排除标准

•1) Combined therapy with PD and hemodialysis. 2) Severe liver disease. 3) Previous severe adverse effect and allergy. 4) Participating other clinical studies. 5) Malignancy, or less than 3 years after treatment of the cancer. 6) Less than 6 months from previous cardiovascular disease (myocardial infarction and apoplexy). 7) More than 8 years PD, or having encapsulating peritoneal sclerosis. 8) Peripheral arterial disease (more than class 2 of Fontaine classification). 9) Uncontrolled hypertension (more than 180mmHg of systolic BP and 120mmHg of diastolic BP). 10) HbA1c >8.0%. 11) Severe anemia (Hb <9.0g/dl) 12) Using aminophylline, theophylline, cholinetheophylline, levodopa, pyridoxal, pyridoxine, and other vitamin B6 agents within 4 weeks. 13) Expected pregnancy within 1 year. 14) Others judged to be excluded by doctors.

研究者

发起方

The University of Tokyo Hospital

相似试验

招募中

2 期

Pyridoxamine for menopausal disordermenopausal disorder with psychological symptoms

JPRN-jRCTs031220256Terauchi Masakazu50

已完成

不适用

Pharmacokinetics test of pyridoxamine in uremic patients on peritoneal dialysisEnd-stage renal disease

JPRN-UMIN000007169Tokai University School of Medicine6

已完成

2 期

The efficacy and safety of pyridoxamine in patients with autism spectrum disorder; Exploratory physician-led Phase 2 trialAutism Spectrum Disorder

JPRN-jRCT2021200001Kure Shigeo78

已完成

2 期

The efficacy and safety of pyridoxamine in patients with autism spectrum disorder; Exploratory physician-led Phase II trialAutism spectrum disorder

JPRN-UMIN000035172Department of Pediatrics,Tohoku University Hospital72

已完成

2 期

The efficacy and safety of pyridoxamine in patients with autism spectrum disorder; Exploratory physician-led Phase 2 trialAutism Spectrum Disorder

JPRN-jRCT2091220438Department of Pediatrics, Tohoku University Hospital79